Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD
In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...
In patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), semaglutide reduced the risk of clinically important kidney...